Direct to Angio Suite
Faster stroke treatment. Improve outcomes
Today more patients can benefit from mechanical thrombectomy through changed guidelines which widen the time to window for endovascular treatment1. Direct To Angio Suite workflows allow for comprehensive stroke diagnoses to be performed directly in the neuro angio suite. This provides valuable, timesaving support for critical patients in acute need of mechanical thrombectomy therapy. At Philips, our goal is to help stroke centers shorten door-to-reperfusion times for ischemic stroke by optimizing workflow and protocols, inspired by established STEMI re-perfusion treatment2.
The Direct to Angio Suite workflow at a glance
Time to reperfusion is fundamental in reducing morbidity and mortality in acute stroke 3,4,5 In patients presenting directly to an endovascular-capable center, emphasis has now been placed on fast door-to-imaging times and fast imaging to groin access times.
Featured products in Direct to Angio Suite
-
Azurion 7 B20/15
Philips Azurion system allows you to perform a wide range of routine and complex interventional procedures easily and confidently with a unique user experience. Advanced capabilities integrated with an innovative system geometry support improved workflow, helping you to optimize your lab performance and provide superior care to your patients.
NCVD016 -
Touch screen module pro
Seamlessly control compatible applications at table side in the sterile field with the enhanced touch screen module Pro. Access physiology, IVUS, hemodynamic measurements, interventional tools and all imaging parameters – to work quickly and decisively. Controlling these applications in the exam room can save time, reduce equipment clutter, and help you focus on the patient.
NCVD081
Video gallery
An interview with (interventional) neurologists about the importance of the direct to angio approach, and the challenges they face.
Dr. Marc Ribó explains how Direct to Angio Suite workflows shorten door-to-reperfusion times for their ischemic stroke patients. This symposium session took place during the ESMINT 2021
Dr. Vitor Mendes Pereira explains how 3D imaging in the angio suite influences faster treatment of ELVOs. This symposium session took place during the LINNC Paris, 2021.
Neuro suite & SmartCT
The Philips Neuro suite offers a flexible portfolio of integrated technologies, services, and neuro accessories that puts you in firm control when treating an acute stroke patient.
Our innovative Neuro suite is already delivering advancements in interventional neuroradiology, such as our industry-leading CT-like SmartCT which provides excellent imaging quality to assist interventional neuroradiologists with diagnosis and treatment.
Stroke care connected
Effective stroke management connects the dots between caregivers at critical moments in stroke care pathways. We're with you, focused on making a life-saving difference for your patients.
Bringing stroke teams together to act fast
Philips partnered with medtech firm Nicolab, integrating its cloud-based stroke triage and management solution StrokeViewer into Philips’ end-to-end stroke care pathway
WE-TRUST in Direct to Angio
We work with leading stroke centers to innovate the stroke care pathway with faster workflow.
WE-TRUST is a multi-center randomized clinical trial sponsored by Philips to assess the impact of the Philips DTAS approach on stroke patient outcomes.
Frequently asked questions
- Why WE-TRUST in Direct to Angio?
-
Philips has a depth of perspective across image guided therapy and the way we treat stroke patients’ clinical processes, and this expertise can help break the boundaries standing in the way of organizing stroke care around the patient.
- What clinical studies are being conducted?
-
We are currently conducting clinical studies at several leading stroke sites to evaluate new acquisition protocols and assess imaging quality (artefact reduction and image reconstruction) of CBCT (Cone-Beam CT) scans in patients with neurovascular diseases, and assess impact on the workflow compared to the standard of care.6
- Is WE-TRUST a Multicenter randomized study?
-
Yes, and in addition to these ongoing studies, Philips will evaluate the potential of these new solutions in the context of a Direct to Angio Suite (DTAS) workflow. A multicenter randomized study Workflow optimization to Reduce Time to endovascular Reperfusion for Ultra-fast Stroke Treatment.
Footnotes
[1] Mokin M, Ansari SA, McTaggart RA, Society of NeuroInterventional Surgery, et al. Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): report of the SNIS Standards and Guidelines Committee, Journal of NeuroInterventional Surgery 2019;11:215-220.
[2] Borja I, Stefan J, Stefan A, et al., ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal, Volume 39, Issue 2, 07 January 2018, Pages 119–177, www.academic.oup.com/eurheartj/article/39/2/119/4095042
[3] Mendez B. et al. 2018. Direct Transfer to Angio-Suite to Reduce Workflow Times and Increase Favorable Clinical Outcome. DOI: 10.1161/STROKEAHA.118.021989
[4] Saver J et al., 2016 Sep 27;316(12):1279-88. doi: 10.1001/jama.2016.13647.
[5] Jadhav AP, et al. Stroke. 2017;48:1884-1889
[6] The product is a work in progress, is not yet CE-marked and is not available for sale. Not for distribution in the USA
